IGF2BP2 and cancer: With regard to cancer, an m6A score based on the expression of IGF2BP2, IGF2BP3, KIAA1429, METTL3, EIF3H, and LRPPRC was reported as an indicator of pancreatic tumor microenvironment status and was a potential biomarker for patients’ prognosis28.